Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats.
about
Post-translational regulation of endothelial nitric oxide synthase in vascular endotheliumNO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialMitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular DysfunctionRNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclaseChaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclaseAGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclasePromoter activity of the 5'-flanking regions of medaka fish soluble guanylate cyclase alpha1 and beta1 subunit genesNitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitroGuanosine 3': 5'-cyclic monophosphate-dependent pathway alterations in ventricular cardiomyocytes of spontaneously hypertensive ratsDownregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive ratsEstrogen, aging and the cardiovascular systemFluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cellsEvidence against oxidative stress as mechanism of endothelial dysfunction in methionine loading model.Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathwayThe fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats.Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysmTargeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vesselsElevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice.Mechanisms underlying the programming of small artery dysfunction: review of the model using low protein diet in pregnancy in the rat.Enhanced hemeoxygenase activity in the rostral ventrolateral medulla mediates exaggerated hemin-evoked hypotension in the spontaneously hypertensive rat.Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease.Regulation of the expression of soluble guanylyl cyclase by reactive oxygen speciesMechanisms underlying endothelial dysfunction in diabetes mellitus: therapeutic implications.Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxideTranscriptional and post-transcriptional regulation of cGMP-dependent protein kinase (PKG-I): pathophysiological significanceDual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activityEffect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclaseRole of aging versus the loss of estrogens in the reduction in vascular function in female rats.Platelet hyperaggregability: impaired responsiveness to nitric oxide ("platelet NO resistance") as a therapeutic target.Nitroxyl donors retain their depressor effects in hypertension.Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.Nitric oxide is less effective at inhibiting neointimal hyperplasia in spontaneously hypertensive rats.Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis.Oxidative stress and endothelial dysfunction in hypertension.Thrombospondin-1, free radicals, and the coronary microcirculation: the aging conundrum.Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.
P2860
Q21129237-8F60EB49-DB77-4525-B37C-8E83525B2959Q24656131-914B4936-AC2E-47E8-B464-73C2A8A2D760Q26799985-C77701AD-27B8-4776-A01B-32B4C095B829Q27001569-ACCB98BC-0671-4A2D-80C0-8707475835ABQ28248976-7D6E43E4-09C9-4E1F-9E86-FD6358B26AA6Q28283420-C679E7FF-36BA-41F9-91B9-C68F1068E11AQ28344298-6BED7E96-B8E6-4ED6-B831-103651CAE732Q28348784-0685D6E6-0A90-4FB5-BCA1-669883D30883Q28361071-5478F66D-3475-43C8-948B-D0D008E8A458Q28362046-B91FB91E-6784-4A5B-9D20-A0FACC427923Q28383144-BBFF5436-B92C-4CC2-9E43-668D1183AA10Q28741339-3432D36A-BDB6-48C6-8DA3-CDFF2F31B06DQ31941042-97665966-4810-46E7-BFCD-6505753DC584Q33683635-5EDBFED3-13DA-4BD7-BB7C-287151A580A8Q34042836-6D339B78-2EF8-480B-9002-B0D0722A7BF8Q34469717-86440739-ED76-48BB-8241-2F8DAE579CE1Q34627792-89E6DDE0-9A40-4155-9418-0ABAE9734C7AQ35009484-B1873029-C776-4A8C-8E5D-E9602B432CBAQ35083693-D81D49C0-E9E0-4D27-B6D7-B4C9B0BC08BEQ35114886-9F86E63F-7B02-450B-AA60-34C11BAE8545Q35265587-30D45667-1526-4529-BC3F-C577F15D11EBQ35771254-E02713B9-F9D4-4495-BD4C-9B7DB4A03B87Q36052610-C61A2530-EB67-4E32-BDDC-C9B7256A73B0Q36176310-118EFB4D-0D7E-42B9-95CA-32E1A13CF9E7Q36309312-A3D574FC-4264-43D8-ABF7-EB74D9749005Q36466804-017C7088-2E46-4156-A85C-F99ABDC61A72Q36529020-CD527789-F3FF-465A-8979-0B5086B09D6CQ36570839-9A7F83C6-9BBA-420F-AC6D-3949215AF561Q36678534-CDF63DAC-D0F8-41D5-B9C0-5CF8E6B996A4Q36938470-A0948CBD-080A-46D2-B4F9-51BE20CD30BEQ37072758-32DBF293-2778-4C62-9331-DCFEF42F87E4Q37104785-D96368BA-D8F9-4E24-B7A3-A74AC490D263Q37142767-45456D4C-FBAF-4BBB-A3EC-7B07B06CB292Q37337510-0DD4F048-A271-4257-A3D3-6081F72B368AQ37420916-3974CBCB-285D-4C42-B5F1-C337700D5DDDQ37424144-D6792A6D-B3D1-4E3B-92B0-B320A2EDBBE7Q37692538-18D22B84-B35D-45CE-B69C-9096AB2857C6Q37867946-D7F326A9-6CF9-40BB-A893-347F01B086AFQ38648723-8E874E63-F144-4391-AA61-D34DC3A52EA7Q38750251-7788C6B8-9826-4017-BCB2-4300A2ABF04C
P2860
Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Downregulation of soluble guan ...... ontaneously hypertensive rats.
@ast
Downregulation of soluble guan ...... ontaneously hypertensive rats.
@en
type
label
Downregulation of soluble guan ...... ontaneously hypertensive rats.
@ast
Downregulation of soluble guan ...... ontaneously hypertensive rats.
@en
prefLabel
Downregulation of soluble guan ...... ontaneously hypertensive rats.
@ast
Downregulation of soluble guan ...... ontaneously hypertensive rats.
@en
P2093
P356
P1433
P1476
Downregulation of soluble guan ...... ontaneously hypertensive rats.
@en
P2093
P304
P356
10.1161/01.RES.85.6.534
P577
1999-09-01T00:00:00Z